ABOUT US
History
2026 ~
Challenges for the Future
2026
- Consolidated business operations of 3 companies (Sungwoo Genetech, Emprotech, USP Tech) into Sungwoo Genetech.
2011 ~ 2025
Expanding Innovation
2019
- Establishment of a Corporate Research Institute
- Patent Registration for a Method of Reducing the Molecular Weight of Hyaluronic Acid
Through Gamma-Ray Irradiation and Treatment with Hyaluronic Acid-Degrading Agents
2016
- Green Cross Signs Contract with LG Life Sciences for New Production Line (Total: 6 billion)
2012
- Annual Revenue Exceeds 10 Billion
2011
- Signing of a Distributorship Agreement with Eaton (U.S.A.)
2006 ~ 2010
The Foundation for Growth
2010
- Hong Jeong-wan Takes Office as CEO
2009
- Establishment of the Daejeon Branch
2008
- Establishment of the Pohang Branch Office
~ 2006
The Beginning of a Leap Forward
1999
- Conversion to a corporation as Sungwoo Genetech, Inc.
1996
- Spun off from Woosung Science Co., Ltd. to become Seongwoo Trading
- (We carry products from MILLIPORE and CAPE COD)
1990
- Establishment of a Daejeon Sales Office within the Daedeok Research Complex
1989
- Signed a Distribution Agreement with Associates of Cape Cod in the U.S.
1986
- Signed a Distribution Agreement with U.S.-based MILLIPORE
1982
- Establishment of Woosung Science Co., Ltd. and Transfer of Operations from Woosung Trading Co., Ltd.
- Signed a Distribution Agreement with Amicon, Inc. of the United States
1977
- Establishment of Woosung Trading Co., Ltd.